公开(公告)号：EP2389168A2

公开(公告)日：2011-11-30

申请号：EP10719783.2

申请日：2010-01-22

申请人： USV Limited

发明人： OMRAY, Ashok ,  CHOUDHARY, Varsha, Shashank ,  BHIDE, Yogesh, Sharad

IPC分类号： A61K9/20 ,  A61K47/38 ,  A61K31/785

CPC分类号： A61K9/2866 ,  A61K9/2018 ,  A61K31/785

摘要： The present invention discloses pharmaceutical composition comprising phosphate binding polymers such as Sevelamer carbonate substantially free of monovalent anion other than bicarbonate anion. Particularly, monovalent anion content is less than about 0.05% (w/w). Disclosed are compositions comprising wet granulated Sevelamer carbonate free of added metal ions and/or added monovalent anion source.

公开(公告)号：EP2187874A2

公开(公告)日：2010-05-26

申请号：EP08852448.3

申请日：2008-08-07

申请人： USV Limited

发明人： HEGDE, Deepak, Anant ,  SHENOY, Sandhya, Rajendra ,  BHATT, Harish, Tulsidutt ,  OMRAY, Ashok

IPC分类号： A61K9/22

CPC分类号： A61K9/2031 ,  A61K9/2009 ,  A61K9/2027 ,  A61K9/205 ,  A61K31/495

摘要： Disclosed herein are sustained release pharmaceutical compositions comprising Trimetazidine or a pharmaceutically acceptable salt thereof and release modifying agents together with suitable pharmaceutically acceptable excipients. The sustained release pharmaceutical compositions of the present invention are characterized by the absence of cellulose and/or their derivatives as release modifying agents.

公开(公告)号：EP2503996A2

公开(公告)日：2012-10-03

申请号：EP10812951.1

申请日：2010-11-26

申请人： USV Limited

发明人： OMRAY, Ashok ,  SHENOY, Sandhya Rajendra ,  BHATT, Harish, Tulsidutt

IPC分类号： A61K9/28

CPC分类号： A61K9/4808 ,  A61K9/2009 ,  A61K9/2018 ,  A61K9/2027 ,  A61K9/2031 ,  A61K9/205 ,  A61K9/2054 ,  A61K9/2866 ,  A61K31/55

摘要： Disclosed are controlled release pharmaceutical compositions of Galantamine comprising a plurality of matrix mini tablets comprising Galantamine or its pharmaceutically acceptable salt and at least one release modifying agent. Said compositions are characterized by the absence of release rate modifying coating and/or absence of an immediate release portion of the Galantamine.

摘要翻译： 公开了加兰他敏的控释药物组合物，其包含多个包含加兰他敏或其药学上可接受的盐和至少一种释放调节剂的基质迷你片剂。 所述组合物的特征在于不存在释放速率改变涂层和/或没有立即释放部分的加兰他敏。

公开(公告)号：EP2155168A2

公开(公告)日：2010-02-24

申请号：EP08738409.5

申请日：2008-04-08

申请人： USV Limited

发明人： HEGDE, Deepak, Anant ,  CHOTHE, Santosh, Sadashiv ,  GHOGARI, Imran, Shakur ,  OMRAY, Ashok

IPC分类号： A61K9/20 ,  A61K9/28 ,  A61K31/4365

CPC分类号： A61K9/2009 ,  A61K9/2013 ,  A61K9/2027 ,  A61K9/2054 ,  A61K9/2866 ,  A61K31/4365

摘要： The present invention discloses novel stable oral pharmaceutical compositions comprising the active ingredient Clopidogrel bisulfate and hydrophilic polymers along with pharmaceutically acceptable excipients. Particularly, the said Clopidogrel bisulfate is crystalline Form 1 and the composition additionally comprises of one or more chelating agents and antioxidants. Further the invention relates to a novel process for preparation of stable pharmaceutical compositions wherein the Clopidogrel bisulfate Form I is coated with a hydrophilic polymer thereby providing an increased physical and chemical stability to the composition.